10x GenomicsTXG
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
盤後
66.98
+0.60
(+0.90%)
01/01 08:00 (UTC+8)
10x GenomicsTXG
0
0
(0%)
財務數據
損益表
- 1.41
- 1.53
- 1.52
- 1.65
- 1.55
- 1.73
- 1.49
- 1.66
- 1.51
- 1.51
- -23.36
- 8.58
- -0.95
- 8.81
- -6.14
- 11.64
- -13.83
- 11.43
- -9.15
- 0.13
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 151,036 | 150,843 | 166,030 | 149,002 | 172,908 | 154,883 | 165,021 | 151,654 | 153,104 | 141,006 |
營業成本 | 38,539 | 44,665 | 52,985 | 48,695 | 47,824 | 49,438 | 54,066 | 45,261 | 48,884 | 48,092 |
營業毛利 | 112,497 | 106,178 | 113,045 | 100,307 | 125,084 | 105,445 | 110,955 | 106,393 | 104,220 | 92,914 |
營業費用 | 132,052 | 123,224 | 132,586 | 132,549 | 94,958 | 144,773 | 160,794 | 147,878 | 145,957 | - |
研發費用 | 56,791 | 56,847 | 55,969 | 57,194 | 61,224 | 64,245 | 66,968 | 66,174 | 62,918 | 68,638 |
推銷及管理費用 | 75,261 | 66,377 | 76,617 | 75,355 | 33,734 | 80,528 | 93,826 | 81,704 | 83,039 | 85,774 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -19,555 | -17,046 | -19,541 | -32,242 | 30,126 | -39,328 | -49,839 | -41,485 | -41,737 | -61,498 |
其他收入及費用 | 910 | 4,199 | 4,348 | 4,034 | 6,874 | 5,822 | 1,459 | 7,049 | 4,659 | 3,696 |
利息費用 | - | - | - | -3 | 3 | - | - | 2 | 1 | 1 |
稅前純益 | -18,645 | -12,847 | -15,193 | -28,205 | 36,997 | -33,506 | -48,380 | -34,438 | -37,079 | -57,803 |
所得稅 | -714 | 623 | 1,059 | -733 | 2,459 | 852 | 648 | 1,315 | 818 | 2,146 |
稅後純益 | -17,931 | -13,470 | -16,252 | -27,472 | 34,538 | -34,358 | -49,028 | -35,753 | -37,897 | -59,949 |
基本每股稅後盈餘(元) | -0.14 | -0.10 | -0.13 | -0.22 | 0.28 | -0.28 | -0.40 | -0.30 | -0.32 | -0.50 |
稀釋每股稅後盈餘(元) | -0.14 | -0.10 | -0.13 | -0.22 | 0.28 | -0.28 | -0.41 | -0.29 | -0.32 | -0.50 |
基本平均股數(千股) | 129984.00 | 128291.00 | 127078.00 | 125502.00 | 123755.00 | 122606.00 | 121596.00 | 120733.00 | 120066.00 | 119394.00 |
稀釋平均股數(千股) | 129984.00 | 128291.00 | 127078.00 | 125502.00 | 123755.00 | 122606.00 | 121596.00 | 120733.00 | 120066.00 | 119394.00 |
還原基本每股稅後盈餘(元) | -0.14 | -0.10 | -0.13 | -0.22 | 0.28 | -0.28 | -0.40 | -0.30 | -0.32 | -0.50 |
還原稀釋每股稅後盈餘(元) | -0.14 | -0.10 | -0.13 | -0.22 | 0.28 | -0.28 | -0.41 | -0.29 | -0.32 | -0.50 |
還原基本平均股數(千股) | 129,984 | 128,291 | 127,078 | 125,502 | 123,755 | 122,606 | 121,596 | 120,733 | 120,066 | 119,394 |
還原稀釋平均股數(千股) | 129,984 | 128,291 | 127,078 | 125,502 | 123,755 | 122,606 | 121,596 | 120,733 | 120,066 | 119,394 |
EBITDA(千元) | -8,981 | -2,890 | -3,093 | -12,329 | 48,443 | -23,692 | -37,816 | -23,686 | -26,178 | -46,308 |